Searched for
CRITICAL LIMB ISCHEMIA.
Mother of two gets new hands after accident, 12 hour transplant brings fresh hopeA young mother received a new lease on life after a successful bilateral hand transplant. The complex 12-hour surgery was performed by spec...- Silent disease threatens legs — here’s how to spot the danger early, as per doctorsPeripheral artery disease (PAD), affecting millions, often goes unnoticed, especially in early stages. Risk factors include age, genetics, ...
- 5 overlooked hand symptoms that may point to artery blockagesBlocked arteries can manifest in subtle hand symptoms long before critical events like heart attacks. Sharp pain, finger discoloration, and...
- You know what’s a heart attack. But a leg attack?Most patients and many doctors are unable to diagnose this condition, called a leg attack. But if not treated in time, it can cost you a li...
- Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patientsStempeucel exhibits potent immuno-modulatory and anti-inflammatory properties which could help in reducing the inflammation caused due to t...
- Stempeutics Research receives patent for critical limb ischemia treatment method"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research s...
- Nikkei closes lower as ex-dividend stocks fizzle outThe Nikkei share average ended down 0.2 per cent, or 49.66 points, to 21,378.73.
- Stempeutics partners with Cipla for its stem cell drugFounded in 2006 by Manipal Education and Medical Group (MEMG), Stempeutics later entered into an alliance with Cipla in 2009. It is an adva...
- Stempeutics: The startup which uses donor stem cells to treat peripheral artery diseaseAnother company which works in a similar space in India include Kasiak Research, which is a part of Bharat Serums and Vaccines (BSVL).
- Cipla's Stempeutics gets process patent for Stempeucel from JapanStempeutics has received process patent from the Japan for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia.
- Indian biotech firm Stempeutics Research gets China Patent for its novel stem cell drugStempeutics' stem cell-based drugs enable living tissues to repair or replace tissue or organ function lost due to age, disease, damage or ...
- Cipla rallies nearly 3% on getting US patent for stemcell productAt 09:40 a.m.; Cipla was trading 2.4 per cent higher at Rs 742.20. It hit a low of Rs 725 and a high of Rs 744.90 in trade today.
- Indian biotech firm Stempeutics Research gets US Process Patent for its novel stem cell drugBacked by the Manipal Education and Medical Group and drug maker Cipla, Stempeutics makes stem cell-based drugs or regenerative medicine.
Load More
